Loading...
XJPX6029
Market cap9mUSD
Dec 24, Last price  
139.00JPY
1D
-0.71%
1Q
1.46%
Jan 2017
-80.83%
IPO
-52.61%
Name

Artra Group Corp

Chart & Performance

D1W1MN
XJPX:6029 chart
P/E
26.93
P/S
0.32
EPS
5.16
Div Yield, %
0.01%
Shrs. gr., 5y
2.26%
Rev. gr., 5y
5.27%
Revenues
4.50b
-3.74%
1,320,152,0001,490,027,0002,564,070,0003,251,564,0003,759,158,0003,479,200,0002,833,781,0002,426,748,0003,158,240,0004,671,498,0004,497,000,000
Net income
53m
+2,419.01%
145,542,00027,604,000268,734,000148,703,000301,430,000269,930,000-146,664,000-440,763,000-351,121,0002,104,00053,000,000
CFO
217m
P
306,376,00076,218,000158,177,000-178,169,000122,895,000-143,289,000-147,687,000272,183,000-208,565,000-132,554,000217,000,000
Dividend
Dec 29, 20213.5 JPY/sh
Earnings
Feb 12, 2025

Profile

Artra Group Corporation provides support services for acupuncture and osteopathic hospitals in Japan. The company offers billing services; and HONEY-STYLE, a system, which specializes in word-of-mouth/reservation system for acupuncture and moxibustion hospital. It also operates Atlas Store, an EC site that sells consumables for acupuncture and moxibustion hospital; and a portal site providing information for judo reduction teachers, acupuncturists/kyu teachers, and anma massage shiatsu teachers through its website and e-mail magazine, as well as offers nursing care services. The company was formerly known as artra corporation and changed its name to Artra Group Corporation in 2021. Artra Group Corporation was founded in 2005 and is headquartered in Osaka, Japan.
URL
https://www.artra-group.co.jp/
IPO date
Dec 16, 2014
Employees
158
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,497,000
-3.74%
4,671,498
47.91%
3,158,240
30.14%
Cost of revenue
4,441,189
4,635,065
3,340,942
Unusual Expense (Income)
NOPBT
55,811
36,433
(182,702)
NOPBT Margin
1.24%
0.78%
Operating Taxes
19,414
24,751
19,868
Tax Rate
34.79%
67.94%
NOPAT
36,397
11,682
(202,570)
Net income
53,000
2,419.01%
2,104
-100.60%
(351,121)
-20.34%
Dividends
(117)
(243)
(31,025)
Dividend yield
0.01%
0.01%
1.12%
Proceeds from repurchase of equity
74,700
1,039,880
BB yield
-3.96%
-37.54%
Debt
Debt current
348,000
401,928
707,689
Long-term debt
1,192,216
1,509,246
1,730,286
Deferred revenue
223,789
259,879
Other long-term liabilities
216,848
4,441
3,210
Net debt
(680,784)
(100,087)
(187,969)
Cash flow
Cash from operating activities
217,000
(132,554)
(208,565)
CAPEX
(75,000)
(156,378)
(56,200)
Cash from investing activities
(11,000)
(154,172)
(563,837)
Cash from financing activities
(300,000)
(314,624)
895,505
FCF
80,872
(166,648)
(645,985)
Balance
Cash
1,140,000
1,234,142
1,835,494
Long term investments
1,081,000
777,119
790,450
Excess cash
1,996,150
1,777,686
2,468,032
Stockholders' equity
(128,791)
403,652
543,326
Invested Capital
3,328,247
3,014,181
3,569,890
ROIC
1.15%
0.35%
ROCE
1.74%
1.06%
EV
Common stock shares outstanding
9,934
9,772
9,552
Price
190.00
1.60%
187.00
-35.52%
290.00
-5.54%
Market cap
1,887,401
3.28%
1,827,414
-34.03%
2,770,176
2.09%
EV
1,206,617
1,727,327
2,584,423
EBITDA
195,811
183,435
(25,945)
EV/EBITDA
6.16
9.42
Interest
14,624
16,695
10,948
Interest/NOPBT
26.20%
45.82%